Fyarro (Sirolimus)
5 mg/mL · Injection Powder Lyophilized For Suspension
By Aadi Bioscience, Inc.
Sirolimus · Injection, Powder, Lyophilized, For Suspension · 5 mg/mL · IV
- NDC
- 80803-153
- Route
- Intravenous
- Therapeutic class
- Decreased Immunologic Activity [PE], Kinase Inhibitor , Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant , mTOR Inhibitors [MoA]
- Marketing category
- NDA
Package sizes
- 1 VIAL, SINGLE-USE in 1 CARTON (80803-153-50) / 20 mL in 1 VIAL, SINGLE-USENDC 80803-153-50Available to Order
Request This Medication
*Expect a reply within 2 business hours with availability and pricing.
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request a quote
Request this medication.
Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.
- DSCSA-compliant pedigree on every order
- Cold-chain capable where applicable
- Same-day fulfillment available for urgent needs
Related in Oncology & Specialty
See all →Verzenio (Abemaciclib)
50 mg/1 · Tablet
Eli Lilly and Company
Available to Source
Verzenio (Abemaciclib)
200 mg/1 · Tablet
Eli Lilly and Company
Available to Source
Verzenio (Abemaciclib)
100 mg/1 · Tablet
Eli Lilly and Company
Available to Source
Verzenio (Abemaciclib)
150 mg/1 · Tablet
Eli Lilly and Company
Available to Source
